NM_000070.3:c.498+32A>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000070.3(CAPN3):c.498+32A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00376 in 1,469,384 control chromosomes in the GnomAD database, including 143 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 73 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 70 hom. )
Consequence
CAPN3
NM_000070.3 intron
NM_000070.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.931
Publications
2 publications found
Genes affected
CAPN3 (HGNC:1480): (calpain 3) Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008]
CAPN3 Gene-Disease associations (from GenCC):
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
- muscular dystrophy, limb-girdle, autosomal dominant 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- muscular dystrophy, limb-girdle, autosomal dominantInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-42386317-A-C is Benign according to our data. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42386317-A-C is described in CliVar as Benign. Clinvar id is 254873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0585 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN3 | NM_000070.3 | c.498+32A>C | intron_variant | Intron 3 of 23 | ENST00000397163.8 | NP_000061.1 | ||
CAPN3 | NM_024344.2 | c.498+32A>C | intron_variant | Intron 3 of 22 | NP_077320.1 | |||
CAPN3 | NM_173087.2 | c.498+32A>C | intron_variant | Intron 3 of 20 | NP_775110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN3 | ENST00000397163.8 | c.498+32A>C | intron_variant | Intron 3 of 23 | 1 | NM_000070.3 | ENSP00000380349.3 | |||
ENSG00000258461 | ENST00000495723.1 | n.*294+32A>C | intron_variant | Intron 7 of 25 | 2 | ENSP00000492063.1 |
Frequencies
GnomAD3 genomes AF: 0.0177 AC: 2696AN: 152148Hom.: 73 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2696
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00480 AC: 1205AN: 250882 AF XY: 0.00356 show subpopulations
GnomAD2 exomes
AF:
AC:
1205
AN:
250882
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00214 AC: 2821AN: 1317118Hom.: 70 Cov.: 20 AF XY: 0.00184 AC XY: 1218AN XY: 663148 show subpopulations
GnomAD4 exome
AF:
AC:
2821
AN:
1317118
Hom.:
Cov.:
20
AF XY:
AC XY:
1218
AN XY:
663148
show subpopulations
African (AFR)
AF:
AC:
1920
AN:
30698
American (AMR)
AF:
AC:
198
AN:
44536
Ashkenazi Jewish (ASJ)
AF:
AC:
31
AN:
25300
East Asian (EAS)
AF:
AC:
0
AN:
39046
South Asian (SAS)
AF:
AC:
23
AN:
83510
European-Finnish (FIN)
AF:
AC:
0
AN:
53004
Middle Eastern (MID)
AF:
AC:
25
AN:
5528
European-Non Finnish (NFE)
AF:
AC:
347
AN:
979930
Other (OTH)
AF:
AC:
277
AN:
55566
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
141
283
424
566
707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0177 AC: 2698AN: 152266Hom.: 73 Cov.: 32 AF XY: 0.0168 AC XY: 1249AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
2698
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
1249
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
2514
AN:
41552
American (AMR)
AF:
AC:
108
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39
AN:
68010
Other (OTH)
AF:
AC:
28
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
129
258
387
516
645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.